A detailed history of Allspring Global Investments Holdings, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 408,494 shares of LLY stock, worth $325 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares
408,494
Previous 368,913 10.73%
Holding current value
$325 Million
Previous $334 Million 8.35%
% of portfolio
0.58%
Previous 0.56%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$772.14 - $960.02 $30.6 Million - $38 Million
39,581 Added 10.73%
408,494 $362 Million
Q2 2024

Jul 26, 2024

SELL
$724.87 - $909.04 $9.91 Million - $12.4 Million
-13,675 Reduced 3.57%
368,913 $334 Million
Q1 2024

Apr 18, 2024

BUY
$592.2 - $792.28 $55.7 Million - $74.5 Million
94,091 Added 32.61%
382,588 $298 Million
Q4 2023

Jan 25, 2024

BUY
$525.19 - $619.13 $33.3 Million - $39.3 Million
63,451 Added 28.19%
288,497 $168 Million
Q3 2023

Oct 27, 2023

BUY
$434.7 - $599.3 $97.8 Million - $135 Million
225,046 New
225,046 $121 Million
Q2 2023

Jul 18, 2023

BUY
$350.74 - $468.98 $31.4 Million - $42 Million
89,581 Added 82.67%
197,935 $92.8 Million
Q1 2023

Apr 13, 2023

BUY
$310.63 - $364.82 $2.62 Million - $3.08 Million
8,434 Added 8.44%
108,354 $37.2 Million
Q4 2022

Jan 23, 2023

SELL
$321.55 - $374.67 $6.5 Million - $7.58 Million
-20,225 Reduced 16.83%
99,920 $0
Q3 2022

Oct 26, 2022

BUY
$296.48 - $337.87 $9.26 Million - $10.6 Million
31,249 Added 35.15%
120,145 $38.8 Million
Q2 2022

Jul 25, 2022

SELL
$278.73 - $327.27 $23.5 Million - $27.6 Million
-84,210 Reduced 48.65%
88,896 $28.8 Million
Q1 2022

May 02, 2022

SELL
$234.69 - $291.66 $18.4 Million - $22.9 Million
-78,580 Reduced 31.22%
173,106 $49.6 Million
Q4 2021

Jan 28, 2022

BUY
$224.85 - $279.04 $56.6 Million - $70.2 Million
251,686 New
251,686 $69.5 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.